Do you want to contribute to improving human health?

The research group of Professor Anders Kvanta together with Dr. Helder André aims to develop various advanced approaches to treat disease in the eye. In close collaboration with Dr. Fredrik Lanner they have developed efficient methodologies to generate functional retinal pigment epithelial (RPE) cells from embryonic stem cells to treat Age-Related Macular Degeneration (AMD) with a first-in-human clinical trial in development. The laboratories are now taking their next step to establish photoreceptors also. In this project you will be performing cutting edge stem cell biology in the interphase of fundamental-to-translational academic research, and industrial pharmaceutical partners.

Your mission

You will be integrated in both Professor Kvanta and Dr Lanners research groups and develop our program aiming at generating stem cell derived functional photoreceptor to treat retinal degeneration. This includes extensive work both by establishing differentiation strategies and employing the cellular product in our animal disease models.

Your profile

Qualified to be employed as a postdoctor is one who has obtained a doctorate or has equivalent scientific competence. Applicants who have not completed a doctorate at the end of the application period may also apply, provided that all requirements for a completed degree are met before the (intended) date of employment. This must be substantiated by the applicant’s main supervisor, director or equivalent.

Prior experience of stem cell culture and differentiation is required and a background in related differentiations are preferable. Experience in flow cytometry, imaging, genome editing, transcriptional analysis, biomaterials and ophthalmology are all beneficial.

Excellent communication skills with documented history, ability to easily integrate into the laboratory environment and interact both socially and scientifically with other colleagues and collaborators is essential (working language reverts to English recurrently). The ideal candidate should be ambitious, strongly motivated and independent to develop the project and successfully troubleshoot emerging issues.

What do we offer?

Karolinska Institutet is one of the world’s leading medical universities. Our vision is to pursue the development of knowledge about life and to promote better health for all. At Karolinska Institutet, we conduct innovative medical research and provide the largest range of biomedical education in Sweden. Karolinska Institutet is a state university, which entitles employees to several benefits such as extended holiday and a generous occupational pension. Employees also have free access to our modern gym and receive reimbursements for medical care.

Application

An employment application must contain the following documents in English or Swedish:

  • A complete resumé, including date of the thesis defence, title of the thesis, previous academic positions, academic title, current position, academic distinctions, and committee work
  • A complete list of publications
  • A summary of current work (no more than one page)

Welcome to apply at the latest 3rd of January 2021

The application is to be submitted through the Varbi recruitment system.

Want to make a difference? Join us and contribute to better health for all!

Type of employmentTemporary position longer than 6 months
Contract typeFull time
First day of employmentAccording to agrement
SalaryMonthly salary
Number of positions1
Working hours100%
CityStockholm
CountyStockholms län
CountrySweden
Reference number
ContactAnders Kvanta, Research group leader, [email protected] Wendel, HR-Administrator, [email protected]
Union representativeHenry Wölling, SEKO, [email protected] Amir, SACO, 08 – 517 733 37Venus Azhary, OFR, 0707-124 127
Published02.Dec.2020
Last application date03.Jan.2021 11:59 PM CET

Apply:

https://ki.varbi.com/en/what:job/jobID:366615/#.X8eQnuJB0Gs.linkedin

Leave a Reply

Your email address will not be published. Required fields are marked *

100K Views

We Reached 100K All-Time Views in a short time (Feb 2021 - onward), AlhamdulAllah. This was not possible without you.

We Deeply appreciate our respected viewers for their consistent Love. Please also recommend and share our site with others. Spread the message.

You have Successfully Subscribed!

error: Alert: Content is protected !!